{"id":6959,"date":"2021-11-05T10:07:12","date_gmt":"2021-11-05T09:07:12","guid":{"rendered":"http:\/\/www.seventure.fr\/wp-content\/uploads\/2021\/11\/211103_MaaT-Pharma_Pricing-PR-EN-FINAL.pdf"},"modified":"2021-11-05T10:07:12","modified_gmt":"2021-11-05T09:07:12","slug":"211103_maat-pharma_pricing-pr-en-final","status":"inherit","type":"attachment","link":"https:\/\/www.seventure.fr\/en\/maat-pharma-announces-successful-initial-public-offering-on-the-regulated-market-of-euronext-paris\/211103_maat-pharma_pricing-pr-en-final\/","title":{"rendered":"211103_MaaT Pharma_Pricing PR EN FINAL"},"author":5,"featured_media":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false},"class_list":["post-6959","attachment","type-attachment","status-inherit","hentry"],"acf":[],"yoast_head":"\n